Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
| Business Activity | PASS |
| Debt Ratio (0.49%) | FAIL |
| Cash Ratio (0.01%) | PASS |
| Receivables Ratio (0.19%) | PASS |
| Revenue Ratio (0.00%) | PASS |
| Overall | FAIL |
| Date | EPS Est. | Reported EPS | Surprise % |
|---|---|---|---|
| 2026-07-30 | 0.37 | Pending | — |
| 2026-04-30 | 0.31 | 0.36 | +15.9% |
| 2026-02-12 | 0.54 | 0.44 | -17.8% |
| 2025-10-30 | 0.60 | 0.69 | +15.4% |
| 2025-07-31 | 0.61 | 0.59 | -3.3% |
| 2025-05-01 | 0.48 | 0.55 | +13.8% |
| 2025-02-20 | 0.53 | 0.58 | +9.6% |
| 2024-11-08 | 0.78 | 0.80 | +3.0% |
| Period | Revenue | Net Income | EBITDA | Gross Profit | Op. Income | EPS |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2.7B | -$15.0M | $309.0M | $891.0M | $66.0M | -0.03 |
| 2025-12-31 | $3.0B | -$1.1B | -$447.0M | $577.0M | -$244.0M | -2.19 |
| 2025-09-30 | $2.8B | -$46.0M | $426.0M | $950.0M | $172.0M | -0.09 |
| 2025-06-30 | $2.8B | $91.0M | $462.0M | $991.0M | $191.0M | 0.18 |
| 2025-03-31 | $2.6B | $126.0M | $325.0M | $861.0M | $58.0M | -0.03 |
| 2024-12-31 | — | — | — | — | — | — |
| Date | Name | Role | Shares | Value |
|---|---|---|---|---|
| 2026-05-05 | MCDONNELL MICHAEL R | Director | 12,836 | — |
| 2026-05-05 | WILKES DAVID S. M.D. | Director | 12,836 | — |
| 2026-05-05 | AMPOFO WILLIAM A. II | Director | 12,836 | — |
| 2026-05-05 | WENDELL AMY MCBRIDE | Director | 12,836 | — |
| 2026-05-05 | SHAFER DAVID BRENT | Chairman of the Board | 12,836 | — |
| 2026-05-05 | SCHLICHTING NANCY M | Director | 12,836 | — |
| 2026-05-05 | CRAIG JEFFREY A | Director | 12,836 | — |
| 2026-05-05 | MORRISON PATRICIA B | Director | 12,836 | — |
| 2026-02-27 | ROSENBLOOM DAVID S | General Counsel | 26,709 | — |
| 2026-02-27 | HIDER ANDREW P | Chief Executive Officer | 201,804 | — |
| Holder | Shares | Value | % Held |
|---|---|---|---|
| Blackrock Inc. | 79.4M | $1.5B | 0.2% |
| Pzena Investment Management LLC | 64.5M | $1.2B | 0.1% |
| Dodge & Cox Inc. | 57.3M | $1.1B | 0.1% |
| FMR, LLC | 46.3M | $887.4M | 0.1% |
| Vanguard Capital Management LLC | 33.5M | $642.7M | 0.1% |
| Vanguard Portfolio Management LLC | 24.0M | $460.2M | 0.0% |
| State Street Corporation | 20.0M | $383.2M | 0.0% |
| Greenhaven Associates, Inc. | 14.3M | $274.4M | 0.0% |
| Geode Capital Management, LLC | 13.8M | $264.0M | 0.0% |
| Invesco Ltd. | 13.1M | $251.7M | 0.0% |
Buy
Hold
Sell
Strong Sell
$17.5B
1.64
0.621
13
$11.3B
$9.7B
111.0%
2.67
4.55
0.1%
37,500
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| 2026-07-30 | $0.37 | Pending | — |
| 2026-04-30 | $0.31 | $0.36 | +15.9% |
| 2026-02-12 | $0.54 | $0.44 | -17.8% |
| 2025-10-30 | $0.60 | $0.69 | +15.4% |
| 2025-07-31 | $0.61 | $0.59 | -3.3% |
| 2025-05-01 | $0.48 | $0.55 | +13.8% |
| Shares | Cost | Profit to Target | R:R |
|---|---|---|---|
| To Consensus ($22.12, 13 analysts) | |||
| 10 | $179.90 | +$41.30 (23%) | 1.5R |
| 50 | $899.50 | +$206.50 (23%) | 1.5R |
| 100 | $1,799.00 | +$413.00 (23%) | 1.5R |
| To Fair Value ($40.00) | |||
| 10 | $179.90 | +$220.10 (122%) | 8.2R |
| 50 | $899.50 | +$1,100.50 (122%) | 8.2R |
| 100 | $1,799.00 | +$2,201.00 (122%) | 8.2R |
- Elevated short interest (4.55 days to cover)
A single score combining all analytical layers below. A is strongest, D is weakest.
How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.
Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.
| Ticker | Correlation |
|---|---|
| ALGN | 0.546 |
| AIN | 0.490 |
| EXR | 0.488 |
| WOOD | 0.486 |
| XLV | 0.479 |
| Ticker | Correlation |
|---|---|
| QIC.KW | -0.449 |
| PAPER.KW | -0.164 |
| 9590.SR | -0.149 |
| 6033.KL | -0.143 |
| 8210.SR | -0.138 |
Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.
After this company beats earnings, does the price keep going up? Drift tracks post-earnings momentum.
How does this ticker’s recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.
Related Tickers
Similar in Healthcare
Also in TE500